iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding iSpecimen Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 7 | +7 |
| Shares | 0 | 1.12M | +1.12M |
| Value | $0 | $8.10M | +$8.10M |
New holders (7)
Institutions that held iSpecimen Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bleichroeder LP | 600,291 | $4.33M | 0.65% |
| NewGen Asset Management Ltd | 250,000 | $1.80M | 0.82% |
| Kepos Capital LP | 225,000 | $1.63M | 0.12% |
| Jane Street Group, LLC | 28,811 | $208.0K | 0.00% |
| Susquehanna International Group, LLP | 11,842 | $85.0K | 0.00% |
| Lindbrook Capital, LLC | 5,000 | $36.0K | 0.01% |
| UBS Group AG | 420 | $3.00K | 0.00% |
Sold out (0)
Institutions that held iSpecimen Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.